Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone

被引:90
作者
Safer, JD
Cohen, RN
Hollenberg, AN
Wondisford, FE
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Thyroid Unit, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.1074/jbc.273.46.30175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
On positive thyroid hormone response elements (pTREs), thyroid hormone receptor (TR) binding to DNA in the absence of ligand (thyroid hormone, T-3) decreases transcription (silencing). Silencing is due to a family of recently described nuclear corepressor proteins (NCoR and SMRT) which bind to the CoR box in the hinge region of TR. Ligand-dependent activation of TR is associated with displacement of corepressors and recruitment of coactivating proteins. Resistance to thyroid hormone (RTH) is due to mutations in the beta isoform of the thyroid hormone receptor (TR-beta). To date, three RTH mutations reportedly with near-normal T-3 binding (A234T, R243Q, and R243W) have been described in or near the CoR box. To determine the mechanism of RTH caused by these mutants, the interaction of wild type (wt) and mutant TRs with the corepressor, NCoR, and the coactivator, SRC-1, was tested in gel-shift assays. As expected, NCoR bound wt TR in the absence of T-3 and dissociated from TR with increasing T-3 concentration. SRC-1 failed to bind wt TR in the absence of T-3, but bound to TR with increasing avidity as T-3 concentrations rose. At no T-3 concentration did both NCoR and SRC-1 bind to wt TR, indicating that their binding to TR was mutually exclusive. Hinge mutants bound NCoR normally in the absence of T-3; however, dissociation of NCoR and recruitment of SRC-1 was markedly impaired except at very high T-3 concentrations. Importantly, hinge mutant TRs when complexed to DNA bound T-3 poorly despite their near normal T-3 binding in solution. These binding studies correlated with functional assays showing defective transactivation of pTREs by hinge mutants except at high T-3 concentrations. Thus, we describe a novel mechanism of RTH whereby TR hinge mutants selectively affect T-3 binding when complexed to DNA, and prevent NCoR dissociation from TR. Our data also suggest that solution T-3 binding by RTH mutants may not accurately reflect physiologically relevant T binding by TR when bound to DNA.
引用
收藏
页码:30175 / 30182
页数:8
相关论文
共 57 条
  • [1] GENETIC-ANALYSIS OF 29 KINDREDS WITH GENERALIZED AND PITUITARY RESISTANCE TO THYROID-HORMONE - IDENTIFICATION OF 13 NOVEL MUTATIONS IN THE THYROID-HORMONE RECEPTOR-BETA GENE
    ADAMS, M
    MATTHEWS, C
    COLLINGWOOD, TN
    TONE, Y
    BECKPECCOZ, P
    CHATTERJEE, KK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) : 506 - 515
  • [2] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
    Anzick, SL
    Kononen, J
    Walker, RL
    Azorsa, DO
    Tanner, MM
    Guan, XY
    Sauter, G
    Kallioniemi, OP
    Trent, JM
    Meltzer, PS
    [J]. SCIENCE, 1997, 277 (5328) : 965 - 968
  • [3] KINDRED S-THYROID HORMONE RECEPTOR IS AN ACTIVE AND CONSTITUTIVE SILENCER AND A REPRESSOR FOR THYROID-HORMONE AND RETINOIC ACID RESPONSES
    BANIAHMAD, A
    TSAI, SY
    OMALLEY, BW
    TSAI, MJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10633 - 10637
  • [4] THE TAU-4 ACTIVATION DOMAIN OF THE THYROID-HORMONE RECEPTOR IS REQUIRED FOR RELEASE OF A PUTATIVE COREPRESSOR(S) NECESSARY FOR TRANSCRIPTIONAL SILENCING
    BANIAHMAD, A
    LENG, XH
    BURRIS, TP
    TSAI, SY
    TSAI, MJ
    OMALLEY, BW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) : 76 - 86
  • [5] A TRANSFERABLE SILENCING DOMAIN IS PRESENT IN THE THYROID-HORMONE RECEPTOR, IN THE V-ERBA ONCOGENE PRODUCT AND IN THE RETINOIC ACID RECEPTOR
    BANIAHMAD, A
    KOHNE, AC
    RENKAWITZ, R
    [J]. EMBO JOURNAL, 1992, 11 (03) : 1015 - 1023
  • [6] MODULAR STRUCTURE OF A CHICKEN LYSOZYME SILENCER - INVOLVEMENT OF AN UNUSUAL THYROID-HORMONE RECEPTOR-BINDING SITE
    BANIAHMAD, A
    STEINER, C
    KOHNE, AC
    RENKAWITZ, R
    [J]. CELL, 1990, 61 (03) : 505 - 514
  • [7] A POINT MUTATION (ALA229 TO THR) IN THE HINGE DOMAIN OF THE C-ERBA-BETA THYROID-HORMONE RECEPTOR GENE IN A FAMILY WITH GENERALIZED THYROID-HORMONE RESISTANCE
    BEHR, M
    LOOS, U
    [J]. MOLECULAR ENDOCRINOLOGY, 1992, 6 (07) : 1119 - 1126
  • [8] FUNCTIONAL EVIDENCE FOR LIGAND-DEPENDENT DISSOCIATION OF THYROID-HORMONE AND RETINOIC ACID RECEPTORS FROM AN INHIBITORY CELLULAR FACTOR
    CASANOVA, J
    HELMER, E
    SELMIRUBY, S
    QI, JS
    AUFLIEGNER, M
    DESAIYAJNIK, V
    KOUDINOVA, N
    YARM, F
    RAAKA, BM
    SAMUELS, HH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) : 5756 - 5765
  • [9] NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR
    CAVAILLES, V
    DAUVOIS, S
    LHORSET, F
    LOPEZ, G
    HOARE, S
    KUSHNER, PJ
    PARKER, MG
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3741 - 3751
  • [10] Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
    Chen, HW
    Lin, RJ
    Schiltz, RL
    Chakravarti, D
    Nash, A
    Nagy, L
    Privalsky, ML
    Nakatani, Y
    Evans, RM
    [J]. CELL, 1997, 90 (03) : 569 - 580